Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

ACHL

Case Managers and Their Role in Improving Patient Outcomes in Idiopathic Pulmonary Fibrosis

Access Activity

Overview / Abstract:

Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients’ quality of life and diminishes life expectancy. Newer therapies slow lung function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. Case managers and respiratory therapists need education on the new therapies and supportive care to educate and counsel patients with IPF, as well as optimize their care.

This text-based activity will educate case managers and registered respiratory therapists (RRT) on the current management of idiopathic pulmonary fibrosis (IPF) and newer therapies that may impact treatment paradigms and patient outcomes. In addition to text, this activity includes audio clips featuring faculty commentary and an ask-the-expert feature. The format is conducive to viewing online and on tablets and smartphones.

Upon completion of this activity, participants will be able to:
•Discuss the burden of IPF on patient quality of life over the disease course
•Evaluate the efficacy, tolerability, and safety data for pharmacotherapies for IPF
•Counsel IPF patients and their caregivers on supportive care and pharmacologic approaches
•Assist with comprehensive care plans and appropriate referral to specialists

Expiration

Apr 28, 2018

Discipline(s)

Counselor CE, Dietetics / Dietitian CE, Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Respiratory Therapy CE, Social Work CE

Format

Monograph, Online

Credits / Hours

1.0

Accreditation

CCM, CRCE

Presenters / Authors / Faculty

Kathleen Ann Fraser, MSN, MHA, RN-BC, CCM, CRRN
Executive Director
Case Management Society of America
Little Rock, AR

Activity Specialities / Related Topics

Asthma, Case Management, Critical Care / Intensive Care, Education / Teaching, Geriatrics / LTC, Internal Medicine, Otolaryngology, Palliative Care / Hospice, Primary Care, Pulmonary Medicine / COPD

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Genentech, Inc.

Keywords / Search Terms

ACHL Kathy Fraser, Kathleen Fraser, idiopathic pulmonary fibrosis, IPF, Genentech, pulmonology, respiratory therapy, enewsletter, newsletter, CME, CCM, pirfenidone, nintedanib, AARC, CRCE, CMSA, case manager, respiratory therapists, RRT, RT, lung function Free CE CME

Access Activity

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.